Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-210-0 | CAS number: 2387-03-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Data is from BASF study report
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Principles of method if other than guideline:
- The Murine Local Lymph Node Assay (LLNA) is recommended by international test guidelines (e.g. OECD) as an animal test for predicting skin sensitization in humans.The study was performed based on the method of Kimber I. et al. (1994)1. The study procedure was extended according to the publications described in section “Test Guidelines”, which evaluate the skin sensitizing potential of test items by determination of lymph node response using lymph node weight and lymph node cell count as parameters which are set into perspective to ear weight as an indicator of skin irritation.
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-hydroxynaphthalene-1-carbaldehyde [(2-hydroxy-1-naphthyl)methylene]hydrazone
- EC Number:
- 219-210-0
- EC Name:
- 2-hydroxynaphthalene-1-carbaldehyde [(2-hydroxy-1-naphthyl)methylene]hydrazone
- Cas Number:
- 2387-03-3
- Molecular formula:
- C22H16N2O2
- IUPAC Name:
- 1,1'-(hydrazine-1,2-diylidenedimethylylidene)di(2-naphthol)
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report):Pigment Yellow 101 (Chemical Name: 2-hydroxynaphthalene-1-carbaldehyde [(2-hydroxy-1-naphthyl)methylene]hydrazone)- Molecular formula (if other than submission substance):C22H16N202- Molecular weight (if other than submission substance):340,385g/mol- Smiles notation (if other than submission substance):Oc1c(c2c(cccc2)cc1)\C=N\N=C\c1c2c(cccc2)ccc1O- InChl (if other than submission substance):1S/C22H16N2O2/c25-21-11-9-15-5-1-3-7-17(15)19(21)13-23-24-14-20-18-8-4-2-6-16(18)10-12-22(20)26/h1-14,25-26H/b23-13+,24-14+- Substance type:Organic- Physical state:Solid-Purity: 100%- Lot/batch No.:29010809T0
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS- Source:Charles River Laboratories, Research Models and Services,Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld- Age at study initiation:6 – 12 weeks- Weight at study initiation:17.3 g – 21.2 g- Housing:Makrolon cage, type II;Nest-building material: wood wool (Typ NBF E-011);Abedd ® Lab. and Vet. Service GmbH Vienna, Austria.PLEXX mouse tunnel (red, transparent) EMSICON Jung GmbH, Forstinning, Germany- Diet (e.g. ad libitum):Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum- Water (e.g. ad libitum):Tap water ad libitum- Acclimation period:7 days before the first test-item applicationENVIRONMENTAL CONDITIONS- Temperature (°C):20 – 24°C- Humidity (%):30 – 70% for relative humidity- Air changes (per hr):No details- Photoperiod (hrs dark / hrs light):12 h / 12 h (6.00 a.m. – 6.00 p.m. / 6.00 p.m. – 6.00 a.m.)
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- propylene glycol
- Concentration / amount:
- 30% in propylene glycol
Challengeopen allclose all
- Route:
- other: intravenously
- Vehicle:
- propylene glycol
- Concentration / amount:
- 30% in propylene glycol
- No. of animals per dose:
- Total no of animals-10 Teastitem-5 animalsControl-5 animals
- Details on study design:
- RANGE FINDING TESTS:MAIN STUDYA. INDUCTION EXPOSURE- No. of exposures: once- Exposure period: day 0 – day 2- Test groups:5- Control group:5- Site: Dorsal part of both ears- Frequency of applications:3 consecutive applications (day 0 – day 2) to the same application site- Duration: - Concentrations:30% in vehicleB. CHALLENGE EXPOSURE- No. of exposures:once- Day(s) of challenge: 5 days- Exposure period: 66 to 72 hours after the last application of test item to the ears- Test groups:5- Control group:5- Site: tail vein.- Concentrations:30% in vehicle- Evaluation (hr after challenge): Immediately after death OTHER:
- Positive control substance(s):
- no
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- Control group 1: Vehicle: propylene glycolTest group 2: Test item 30% in propylene glycol
- No. of animals per dose:
- Group 1 -5 animalsGroup 2- 5 animals
- Details on study design:
- Conduct of the study:The study comprised one treatment group and a vehicle control group. Each group consisted of 5 mice.Randomization: Prior to first application, the animals were distributed to the individual groups, received their animal numbers and were allocated to the respective cages according to the randomization instructions of „Nijenhuis, A. and Wilf, H.S.: Combinatorial Algorithms, Academic Press, New York,San Francisco, London, 1978, pp. 62 – 64“.Body weight determination: Individual body weights on day 0 prior to the first application and on day 5 prior to the sacrifice of the animals.Signs and symptoms: No detailed clinical examination of the individual animals was performed but any obvious signs of systemic toxicity and/orlocal inflammation at the application sites were noted in the raw data.Form of application: Epicutaneous application is simulating dermal contact with the compound which is possible to occur under practical useconditions.Application volume: 25 μL per earSite of application: Dorsal part of both earsFrequency of application: 3 consecutive applications (day 0 – day 2) to the same application siteMortality: Twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.Terminal procedures:The animals were sacrificed on study day 5 about 5 hours after 3H-thymidine injection by cervical dislocation.Determination of ear weight: Immediately after the death of each animal a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each test group. These measurements serve for detecting a potential inflammatory ear swelling.Removal and weightdetermination of the lymph nodes: Immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.Preparation of cell suspension and determination of cell count:After weight determination, the pooled lymph nodes of each test group were stored in phosphate buffered saline in an icewater bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing all lymph nodes per test group through an iron mesh (mesh size 200 μm) into 40 mL of phosphate-buffered physiological saline. For determination of cell counts, analiquot of each suspension was further diluted with Casy®ton in a ratio 1:500. The cell count was determined using a Casy®- Counter.Measurement of 3Hthymidine incorporation of the lymph node cells:The remaining cell suspensions were washed twice with phosphate buffered saline (PBS) and precipitated with 5% trichloro-acetic acid (TCA). Each precipitate was transferred to scintillation fluid and incorporation of 3H-thymidine into the cells was measured in a ß-scintillation counter.
- Positive control substance(s):
- other: Alpha-Hexylcinnamaldehyde
- Statistics:
- Table(s) and/or figure(s) of measured parameters presented in the report were produced using PC based tabular calculation software. The mean and individual data were not always rounded but the significant digits were produced by changing the display format. As a consequence, calculation of mean values using the individual data presented in the report will, in some instances, yield minor variations in value.
Results and discussion
- Positive control results:
- The sensitivity of mice (CBA/CaOlaHsd, Harlan Winkelmann GmbH, Borchen, Germany or CBA/J, Charles River Laboratories, Research Models and Services, Germany GmbH,Sandhofer Weg 7, 97633 Sulzfeld) and the reliability of experimental techniques was assessed regularly using a known sensitizer as recommended by the test guidelines.Positive results were consistently obtained over the years using several variations of the methods and different vehicles.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: 1st reading. Group: test group. Dose level: 30%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: not sensitizing according to stimulation index reading.
- Parameter:
- SI
- Remarks on result:
- other: no increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5no increase above the cut off stimulation index of 3
Any other information on results incl. tables
CELL COUNT, 3H-THYMIDINE INCORPORATION AND LYMPH NODE WEIGHT: TEST GROUP MEAN VALUES AND STIMULATION INDICES
|
| Cell Counts | |
Test Group | Treatment | [Counts/Lymph Node Pair] | Stimulation Index1 |
1 | vehicle propylene glycol | 5,808,000 | 1.00 |
2 | 30% in propylene glycol | 6,902,667 | 1.19 |
|
| ³H-thymidine incorporation | |
Test Group | Treatment | [DPM/Lymph Node Pair] | Stimulation Index1 |
1 | vehicle propylene glycol | 362.1 | 1.00 |
2 | 30% in propylene glycol | 883.3 | 2.44 |
|
| Lymph Node Weight | |
Test Group | Treatment | [mg/Lymph Node Pair] | Stimulation Index1 |
1 | vehicle propylene glycol | 4.3 | 1.00 |
2 | 30% in propylene glycol | 4.8 | 1.13 |
EAR WEIGHT: TEST GROUP MEAN VALUES AND STIMULATION INDICES
|
| Ear Weight | |
Test Group | Treatment | [mg/animal] | Stimulation Index1 |
1 | vehicle propylene glycol | 31.2 | 1.00 |
2 | 30% in propylene glycol | 34.3 | 1.00 |
1test group x / test group 1 (vehicle control)
BODY WEIGHT DATA
Treatment | Animal No. | Body Weight d0 [g] | Body Weight d5 [g] | Body Weight Change d5-d0 [g] | ||||||
Individual | Mean | S.D. | Individual | Mean | S.D. | Individual | Mean | S.D. | ||
vehicle propylene glycol | 1 | 21.2 | 19.4 | 1.6 | 23.1 | 20.3 | 1.9 | 1.9 | 0.8 | 0.8 |
2 | 20.0 | 20.9 | 0.9 | |||||||
3 | 17.8 | 19.0 | 1.2 | |||||||
4 | 20.4 | 20.2 | -0.2 | |||||||
5 | 17.8 | 18.2 | 0.4 | |||||||
30% in propylene glycol | 1 | 19.6 | 18.6 | 1.1 | 20.0 | 19.5 | 1.4 | 0.4 | 0.9 | 0.5 |
2 | 19.5 | 21.1 | 1.6 | |||||||
3 | 17.3 | 17.8 | 0.5 | |||||||
4 | 17.4 | 18.3 | 0.9 | |||||||
5 | 19.0 | 20.1 | 1.1 |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- No signs of systemic toxicity were noticed.When applied as a 30% preparation in propylene glycol, the test item did not induce a biologically relevant response (no increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts.There was no relevant increase in lymph node weights, as well.Concomitantly, the increase of 3H-thymidine incorporation into the cells was not biologicallyrelevant (no increase above the cut off stimulation index of 3) at this concentration.The test-item preparation caused some increase in ear weights as indication of ear skin irritation. The ears of the mice were slightly yellow discolored on study days 1 and 2 and on the day of lymph node removal.Thus it is concluded that Pigment Yellow 101 does not show a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
- Executive summary:
The skin sensitizing potential of Pigment Yellow 101 was assessed using the radioactive Murine Local Lymph Node Assay. The assay simulates the induction phase for skin sensitization in mice. It determines the response of the auricular lymph nodes on repeated application of the test item to the dorsal skin of the ears.
Groups of 5 female CBA/J mice each were treated with a 30% w/w preparation of the test item in propylene glycol or with the vehicle alone. The 30% preparation was the maximum technically applicable concentration.
The study used 1 test group and 1 control group. Each test animal was applied with 25 μL per ear of the test-item preparation to the dorsum of both ears for three consecutive days. The control group was treated with 25 μL per ear of the vehicle alone.
Three days after the last application the mice were injected intravenously with 20 μCi of 3H-thymidine in 250 μL of sterile saline into a tail vein. About 5 hours after the 3H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. The weights of each animal’s pooled lymph nodes were determined. Thereafter lymph nodes were pooled group wise and further evaluated by measuring their cellular content and 3H-thymidine incorporation into the lymph node cells (indicators of cell proliferation). Moreover, a defined area with a diameter of 0.8 cm was punched out of the apical part of each ear and for each test group the weight of the pooled punches was determined in order to obtain an indication of possible skin irritation.
No signs of systemic toxicity were noticed.
When applied as a 30% preparation in propylene glycol, the test item did not induce a biologically relevant response (no increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts. There was no relevant increase in lymph node weights, as well.
Concomitantly, the increase of 3H-thymidine incorporation into the cells was not biologically relevant (no increase above the cut off stimulation index of 3) at this concentration.
The test-item preparation caused some increase in ear weights as indication of ear skin irritation. The ears of the mice were slightly yellow discolored on study days 1 and 2 and on the day of lymph node removal.
Thus it is concluded that Pigment Yellow 101 does not show a skin sensitizing effect in the Murine Local Lymph Node Assay under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.